Key Takeaway:
- Flu vaccination was associated with a lower risk of atrial fibrillation (AFib) in a study of more than 1.1 million adults.
- Vaccinated patients also had lower risks of heart attack, heart failure, and all-cause mortality than those who were not vaccinated.
- Researchers say flu shots should be considered part of broader cardiovascular prevention, alongside their role in preventing influenza.
A study published in the European Heart Journal finds that flu vaccination is associated with a lower risk of atrial fibrillation, heart attack, heart failure, and death, based on an analysis of health data from more than 1.1 million adults.
The findings add to growing evidence that influenza vaccination may play a broader role in cardiovascular prevention, supporting its use beyond protection against seasonal respiratory illness.
Study Connects Flu Vaccination to Lower AFib Risk
Researchers led by Dr. Laurent Fauchier of Trousseau University Hospital in Tours, France, reviewed electronic health records from the TriNetX Global Collaborative Network. The analysis included more than 1.1 million adults who attended routine health care visits in 2022.
Using propensity score matching, the researchers compared approximately 138,000 adults who received Flu Vaccination within the previous year with a similar-sized group that did not receive the vaccine. Participants were followed for an average of 2.7 years.
The study found annual atrial fibrillation rates of 0.89% among vaccinated patients compared with 1.12% among those who were not vaccinated. Vaccinated patients also experienced lower risks of all-cause mortality, myocardial infarction, and heart failure.
Researchers Say Vaccines Support Heart Disease Prevention
The researchers said the results reinforce evidence that Flu Vaccination provides cardiovascular benefits in addition to preventing infection.
“Beyond preventing respiratory illness, accumulating evidence indicates that influenza vaccination confers cardiovascular protection,” Fauchier and his colleagues wrote in the study. They said previous randomized trials and observational studies have shown fewer deaths and cardiovascular hospitalizations among people at high risk, particularly those with heart failure or established cardiovascular disease.
The authors said the findings reflect a shift in how Flu Vaccination is viewed. Rather than serving only as protection against infectious disease, they said vaccination is increasingly considered part of routine cardiovascular prevention.
The researchers also reported that the benefits remained consistent across different age groups and selected disease subgroups.
Experts Urge Broader Use While Noting Modest Individual Benefit
The researchers cautioned that the reduction in atrial fibrillation risk for individual patients was modest. However, they said even small reductions could produce meaningful public health benefits because atrial fibrillation is common and influenza vaccines have a well-established safety profile.
“From a clinical perspective, these findings support consideration of influenza vaccination as part of comprehensive cardiovascular and AFib prevention strategies in routine care,” the authors wrote.
They emphasized that influenza vaccination should not be viewed as a treatment aimed solely at preventing atrial fibrillation. Instead, they said it should be incorporated into broader strategies designed to reduce cardiovascular risk.
The study was published in the European Heart Journal and was based on observational data from the TriNetX Global Collaborative Network. While the analysis identified strong associations between Flu Vaccination and improved cardiovascular outcomes, the findings do not establish that influenza vaccination directly causes the reduction in atrial fibrillation or other cardiac events.
Visit Healthcare 360 Magazine For The Most Recent Information.
